Ralf Reilmann - Publications

Affiliations: 
Neurology University of Munster, Münster, Nordrhein-Westfalen, Germany 
Area:
Huntington's disease

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Drew CJG, Quinn L, Hamana K, Williams-Thomas R, Marsh L, Dimitropoulou P, Playle R, Griffin BA, Kelson M, Schubert R, Muratori L, Reilmann R, Rosser A, Busse M. Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease. Physical Therapy. PMID 31101920 DOI: 10.1093/ptj/pzz075  0.4
2018 Rieke L, Schubert R, Matheis T, Muratori LM, Motlik J, Schramke S, Fels M, Kemper N, Schuldenzucker V, Reilmann R. Vocalisation as a Viable Assessment for Phenotyping Minipigs Transgenic for the Huntington Gene? Journal of Huntington's Disease. 7: 269-278. PMID 30103340 DOI: 10.3233/JHD-170284  1
2018 Schuldenzucker V, Schubert R, Muratori LM, Freisfeld F, Rieke L, Matheis T, Schramke S, Motlik J, Kemper N, Radespiel U, Reilmann R. Behavioral Assessment of Stress Compensation in Minipigs Transgenic for the Huntington Gene Using Cortisol Levels: A Proof-of-Concept Study. Journal of Huntington's Disease. 7: 151-161. PMID 29843247 DOI: 10.3233/JHD-180285  1
2017 Schuldenzucker V, Schubert R, Muratori LM, Freisfeld F, Rieke L, Matheis T, Schramke S, Motlik J, Kemper N, Radespiel U, Reilmann R. Behavioral testing of minipigs transgenic for the Huntington gene-A three-year observational study. Plos One. 12: e0185970. PMID 29016656 DOI: 10.1371/journal.pone.0185970  1
2016 Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, Roos R, van der Plas AA, Reilmann R, Frich JC, Rickards H, Rosser A, Busse M. A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease. Parkinsonism & Related Disorders. PMID 27423921 DOI: 10.1016/j.parkreldis.2016.06.023  1
2016 Keogh R, Frost C, Owen G, Daniel RM, Langbehn DR, Leavitt B, Durr A, Roos RA, Landwehrmeyer GB, Reilmann R, Borowsky B, Stout J, Craufurd D, Tabrizi SJ. Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance. Plos Currents. 8. PMID 26819833 DOI: 10.1371/currents.hd.8060298fac1801b01ccea6acc00f97cb  1
2015 Hoffmann S, Siedler J, Brandt AU, Piper SK, Kohler S, Sass C, Paul F, Reilmann R, Meisel A. Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study. Bmc Neurology. 15: 265. PMID 26701600 DOI: 10.1186/s12883-015-0517-8  1
2015 Schramke S, Schuldenzucker V, Schubert R, Frank F, Wirsig M, Ott S, Motlik J, Fels M, Kemper N, Hölzner E, Reilmann R. Behavioral phenotyping of minipigs transgenic for the Huntington gene. Journal of Neuroscience Methods. PMID 26688470 DOI: 10.1016/j.jneumeth.2015.11.013  1
2015 Schubert R, Frank F, Nagelmann N, Liebsch L, Schuldenzucker V, Schramke S, Wirsig M, Johnson H, Kim EY, Ott S, Hölzner E, Demokritov SO, Motlik J, Faber C, Reilmann R. Neuroimaging of a minipig model of Huntington's disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessments. Journal of Neuroscience Methods. PMID 26658298 DOI: 10.1016/j.jneumeth.2015.11.017  1
2015 Johnson EB, Rees EM, Labuschagne I, Durr A, Leavitt BR, Roos RA, Reilmann R, Johnson H, Hobbs NZ, Langbehn DR, Stout JC, Tabrizi SJ, Scahill RI. The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease. Neuropsychologia. PMID 26519555 DOI: 10.1016/j.neuropsychologia.2015.10.033  1
2015 Minkova L, Eickhoff SB, Abdulkadir A, Kaller CP, Peter J, Scheller E, Lahr J, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance. Human Brain Mapping. PMID 26453902 DOI: 10.1002/hbm.23014  1
2015 Holtbernd F, Deppe M, Bachmann R, Mohammadi S, Ringelstein EB, Reilmann R. Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study. Bmc Neurology. 15: 190. PMID 26450403 DOI: 10.1186/s12883-015-0451-9  1
2015 Wojtecki L, Groiss SJ, Ferrea S, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Südmeyer M, Ohmann C, Schnitzler A, Vesper J. A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease. Frontiers in Neurology. 6: 177. PMID 26347707 DOI: 10.3389/fneur.2015.00177  1
2015 Reilmann R, Lippross V, Hölzner E, Gigengack F, Bohlen S, Kugel H, Deppe M, Osada N, Lücke M, Riess O, Nguyen HP, Von Hörsten S, Schäfers K, Schäfers M, Jacobs AH, et al. FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study. Journal of Huntington's Disease. 4: 37-47. PMID 26333256 DOI: 10.3233/JHD-130084  1
2015 Maetzler W, Ellerbrock M, Heger T, Sass C, Berg D, Reilmann R. Digitomotography in Parkinson's disease: a cross-sectional and longitudinal study. Plos One. 10: e0123914. PMID 25902182 DOI: 10.1371/journal.pone.0123914  1
2015 Schaeffer E, Maetzler W, Liepelt-Scarfone I, Sass C, Reilmann R, Berg D. Quantitative motor assessment of dyskinesias in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 25712401 DOI: 10.1007/s00702-015-1383-7  1
2015 Sturrock A, Laule C, Wyper K, Milner RA, Decolongon J, Dar Santos R, Coleman AJ, Carter K, Creighton S, Bechtel N, Bohlen S, Reilmann R, Johnson HJ, Hayden MR, Tabrizi SJ, et al. A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 393-401. PMID 25690257 DOI: 10.1002/mds.26118  1
2015 Reilmann R, Rouzade-Dominguez ML, Saft C, Süssmuth SD, Priller J, Rosser A, Rickards H, Schöls L, Pezous N, Gasparini F, Johns D, Landwehrmeyer GB, Gomez-Mancilla B. A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 427-31. PMID 25689146 DOI: 10.1002/mds.26174  1
2015 Angus D, Herd C, Stone C, Stout J, Wieler M, Reilmann R, Ritchie CW, Dorsey ER, Helles K, Kayson E, Oakes D, Rosas HD, Vaughan C, Panegyres PK, Ames D, et al. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: A phase 2, randomised, double-blind, placebo-controlled trial The Lancet Neurology. 14: 39-47. PMID 25467848 DOI: 10.1016/S1474-4422(14)70262-5  1
2015 Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, Roos RAC, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, et al. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study Ebiomedicine. DOI: 10.1016/j.ebiom.2015.08.002  1
2014 Sampaio C, Borowsky B, Reilmann R. Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1419-28. PMID 25216371 DOI: 10.1002/mds.26021  1
2014 Reilmann R, Leavitt BR, Ross CA. Huntington's disease: a field on the move. Introduction. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1333-4. PMID 25164859 DOI: 10.1002/mds.26017  1
2014 Reilmann R, Leavitt BR, Ross CA. Diagnostic criteria for Huntington's disease based on natural history. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1335-41. PMID 25164527 DOI: 10.1002/mds.26011  1
2014 Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews. Neurology. 10: 204-16. PMID 24614516 DOI: 10.1038/nrneurol.2014.24  1
2014 Bank PJ, van Rooijen DE, Marinus J, Reilmann R, van Hilten JJ. Force modulation deficits in complex regional pain syndrome: a potential role for impaired sense of force production. European Journal of Pain (London, England). 18: 1013-23. PMID 24382670 DOI: 10.1002/j.1532-2149.2013.00446.x  1
2013 Crawford HE, Hobbs NZ, Keogh R, Langbehn DR, Frost C, Johnson H, Landwehrmeyer B, Reilmann R, Craufurd D, Stout JC, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Scahill RI, et al. Corpus callosal atrophy in premanifest and early Huntington's disease. Journal of Huntington's Disease. 2: 517-26. PMID 25062736 DOI: 10.3233/JHD-130077  1
2013 Reilmann R. The pridopidine paradox in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1321-4. PMID 23847099 DOI: 10.1002/mds.25559  1
2013 Reilmann R. Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1030-3. PMID 23674480 DOI: 10.1002/mds.25500  1
2013 Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. The Lancet. Neurology. 12: 637-49. PMID 23664844 DOI: 10.1016/S1474-4422(13)70088-7  1
2013 Hart EP, Marinus J, Burgunder JM, Bentivoglio AR, Craufurd D, Reilmann R, Saft C, Roos RA. Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1142-5. PMID 23495076 DOI: 10.1002/mds.25422  1
2013 Squitieri F, Landwehrmeyer B, Reilmann R, Rosser A, de Yebenes JG, Prang A, Ivkovic J, Bright J, Rembratt A. One-year safety and tolerability profile of pridopidine in patients with Huntington disease. Neurology. 80: 1086-94. PMID 23446684 DOI: 10.1212/WNL.0b013e3182886965  1
2013 van den Bogaard SJ, Dumas EM, Hart EP, Milles J, Reilmann R, Stout JC, Craufurd D, Gibbard CR, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up. Ajnr. American Journal of Neuroradiology. 34: 317-22. PMID 22918430 DOI: 10.3174/ajnr.A3303  1
2013 Reilmann R, Holtbernd F, Bachmann R, Mohammadi S, Ringelstein EB, Deppe M. Grasping multiple sclerosis: do quantitative motor assessments provide a link between structure and function? Journal of Neurology. 260: 407-14. PMID 22872165 DOI: 10.1007/s00415-012-6639-7  1
2013 Bohlen S, Ekwall C, Hellström K, Vesterlin H, Björnefur M, Wiklund L, Reilmann R. Physical therapy in Huntington's disease--toward objective assessments? European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 389-93. PMID 22672573 DOI: 10.1111/j.1468-1331.2012.03760.x  1
2013 Delmaire C, Dumas EM, Sharman MA, van den Bogaard SJ, Valabregue R, Jauffret C, Justo D, Reilmann R, Stout JC, Craufurd D, Tabrizi SJ, Roos RA, Durr A, Lehéricy S. The structural correlates of functional deficits in early huntington's disease. Human Brain Mapping. 34: 2141-53. PMID 22438242 DOI: 10.1002/hbm.22055  1
2013 Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehéricy S, Craufurd D, Kennard C, ... ... Reilmann R, et al. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Human Brain Mapping. 34: 519-29. PMID 22102212 DOI: 10.1002/hbm.21449  1
2013 Süßmuth SD, Saft C, Reilmann R, Orth M, Landwehrmeyer GB. Huntington's disease update | Neues zur Huntington-Krankheit Aktuelle Neurologie. 40: 377-392. DOI: 10.1055/s-0033-1345194  1
2012 Reilmann R, Rumpf S, Beckmann H, Koch R, Ringelstein EB, Lange HW. Huntington's disease: objective assessment of posture--a link between motor and functional deficits. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 555-9. PMID 22241673 DOI: 10.1002/mds.24908  1
2012 van den Bogaard SJ, Dumas EM, Milles J, Reilmann R, Stout JC, Craufurd D, van Buchem MA, van der Grond J, Roos RA. Magnetization transfer imaging in premanifest and manifest Huntington disease. Ajnr. American Journal of Neuroradiology. 33: 884-9. PMID 22241387 DOI: 10.3174/ajnr.A2868  1
2012 Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet. Neurology. 11: 42-53. PMID 22137354 DOI: 10.1016/S1474-4422(11)70263-0  1
2012 Reilmann R. Huntington's disease: Towards disease modification - gaps and bridges, facts and opinions Basal Ganglia. 2: 241-248. DOI: 10.1016/j.baga.2012.09.004  1
2011 de Yebenes JG, Landwehrmeyer B, Squitieri F, Reilmann R, Rosser A, Barker RA, Saft C, Magnet MK, Sword A, Rembratt A, Tedroff J. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 10: 1049-57. PMID 22071279 DOI: 10.1016/S1474-4422(11)70233-2  1
2011 Vaccarino AL, Sills T, Anderson KE, Biglan K, Borowsky B, Giuliano J, Guttman M, Ho AK, Kennard C, Kupchak P, Landwehrmeyer GB, Michell A, Paulsen JS, Reilmann R, van Kammen DP, et al. Assessment of motor symptoms and functional impact in prodromal and early huntington disease. Plos Currents. 2: RRN1244. PMID 21804956 DOI: 10.1371/currents.RRN1244  1
2011 Kandasamy M, Reilmann R, Winkler J, Bogdahn U, Aigner L. Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease. Neurology Research International. 2011: 124256. PMID 21766020 DOI: 10.1155/2011/124256  1
2011 Sitek EJ, SoÅ‚tan W, Wieczorek D, Schinwelski M, Robowski P, Reilmann R, GuziÅ„ska K, Harciarek M, Krysa W, SÅ‚awek J. Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia. Journal of the International Neuropsychological Society : Jins. 17: 788-95. PMID 21729402 DOI: 10.1017/S1355617711000725  1
2011 Reilmann R, Bohlen S, Kirsten F, Ringelstein EB, Lange HW. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2267-73. PMID 21661053 DOI: 10.1002/mds.23816  1
2011 López-Sendón JL, Royuela A, Trigo P, Orth M, Lange H, Reilmann R, Keylock J, Rickards H, Piacentini S, Squitieri F, Landwehrmeyer B, Witjes-Ane MN, Jurgens CK, Roos RA, Abraira V, et al. What is the impact of education on Huntington's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1489-95. PMID 21432905 DOI: 10.1002/mds.23385  1
2011 Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet. Neurology. 10: 31-42. PMID 21130037 DOI: 10.1016/S1474-4422(10)70276-3  1
2011 Reilmann R. Progression of premanifest and early Huntington's disease detectable after 1 year-Does TRACK-HD open the door to disease-modifying trials in HD and beyond? Movement Disorders. 26: 605. DOI: 10.1002/mds.23710  1
2010 Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, ... ... Reilmann R, et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 75: 2150-60. PMID 21068430 DOI: 10.1212/WNL.0b013e3182020123  1
2010 Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology. 75: 1702-10. PMID 21060093 DOI: 10.1212/WNL.0b013e3181fc27e4  1
2010 Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW. Grasping premanifest Huntington's disease - shaping new endpoints for new trials. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2858-62. PMID 20818671 DOI: 10.1002/mds.23300  1
2010 Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2195-202. PMID 20645403 DOI: 10.1002/mds.23243  1
2009 Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet. Neurology. 8: 791-801. PMID 19646924 DOI: 10.1016/S1474-4422(09)70170-X  1
2009 Reilmann R. Grip-force analysis in Huntington's disease - A biomarker for clinical trials? Sensorimotor Control of Grasping: Physiology and Pathophysiology. 326-332. DOI: 10.1017/CBO9780511581267.024  1
2008 Horváth R, Reilmann R, Holinski-Feder E, Ringelstein EB, Klopstock T. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA. Neuromuscular Disorders : Nmd. 18: 553-6. PMID 18590963 DOI: 10.1016/j.nmd.2008.05.002  1
2006 Bachmann R, Reilmann R, Schwindt W, Kugel H, Heindel W, Krämer S. FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. European Radiology. 16: 915-21. PMID 16365731 DOI: 10.1007/s00330-005-0070-8  1
2005 Reilmann R, Imai T, Ringelstein EB, Gaubitz M, Niederstadt TU, Paulus W, Husstedt IW. Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1304-5. PMID 16107375 DOI: 10.1136/jnnp.2004.057588  1
2005 Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose M, Gasser T, Klopstock T. Creatine supplementation lowers brain glutamate levels in Huntington's disease. Journal of Neurology. 252: 36-41. PMID 15672208 DOI: 10.1007/s00415-005-0595-4  1
2005 Reilmann R. Motor deficits as biomarkers in Huntington's disease: Perspectives for neuroacanthocytosis syndromes Neuroacanthocytosis Syndromes. 233-242. DOI: 10.1007/1-4020-2898-9_26  1
2004 Konrad C, Vollmer-Haase J, Gaubitz M, Nabavi DG, Reilmann R, Knecht S. Fracture of the odontoid process complicating tardive dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 983-5. PMID 15300672 DOI: 10.1002/mds.20122  1
2003 Muratori LM, Reilmann R, Gordon AM. Coordination of fingertip forces during precision grasping in multiple system atrophy. Neuropsychologia. 41: 1498-508. PMID 12849768 DOI: 10.1016/S0028-3932(03)00092-7  1
2003 Salimi I, Frazier W, Reilmann R, Gordon AM. Selective use of visual information signaling objects' center of mass for anticipatory control of manipulative fingertip forces. Experimental Brain Research. 150: 9-18. PMID 12698211 DOI: 10.1007/s00221-003-1394-8  1
2003 Flöel A, Reilmann R, Frese A, Lüdemann P. Anticonvulsants for Creutzfeldt-Jakob disease? Lancet. 361: 224. PMID 12547547 DOI: 10.1016/S0140-6736(03)12273-8  1
2001 Reilmann R, Gordon AM, Henningsen H. Initiation and development of fingertip forces during whole-hand grasping. Experimental Brain Research. 140: 443-52. PMID 11685397 DOI: 10.1007/s002210100838  1
2001 Reilmann R, Kirsten F, Quinn L, Henningsen H, Marder K, Gordon AM. Objective assessment of progression in Huntington's disease: a 3-year follow-up study. Neurology. 57: 920-4. PMID 11552034  1
2001 Quinn L, Reilmann R, Marder K, Gordon AM. Altered movement trajectories and force control during object transport in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 469-80. PMID 11391741 DOI: 10.1002/mds.1108  1
2000 Gordon AM, Quinn L, Reilmann R, Marder K. Coordination of prehensile forces during precision grip in Huntington's disease. Experimental Neurology. 163: 136-48. PMID 10785452 DOI: 10.1006/exnr.2000.7348  1
1999 Gordon AM, Reilmann R. Getting a grasp on research: does treatment taint testing of parkinsonian patients? Brain : a Journal of Neurology. 122: 1597-8. PMID 10430842 DOI: 10.1093/brain/122.8.1597  1
1997 Reilmann R, Rolf LH, Lange HW. Huntington's disease: N-methyl-D-aspartate receptor coagonist glycine is increased in platelets. Experimental Neurology. 144: 416-9. PMID 9168841 DOI: 10.1006/exnr.1997.6428  1
1995 Reilmann R, Rolf LH, Lange HW. Decreased plasma alanine and isoleucine in Huntington's disease. Acta Neurologica Scandinavica. 91: 222-4. PMID 7793240  1
1994 Reilmann R, Rolf LH, Lange HW. Huntington's disease: the neuroexcitotoxin aspartate is increased in platelets and decreased in plasma. Journal of the Neurological Sciences. 127: 48-53. PMID 7699391 DOI: 10.1016/0022-510X(94)90134-1  1
Show low-probability matches.